Accepted for publacatnon I February 1995 more common than ventricular lead displacement (n = 5, 0*5% of ventricular leads, P = 0.047). There was no difference in electrode displacement rates for dual (1.6%) compared with single (1.2%) chamber systems. Pacemaker pocket infection led to reoperation in 10 patients (six dual, four single chamber, P = not significant) and was significantly more common in patients who had a temporary pacing lead in place at implant (2.9%) than in those who did not (0-4%/o, P = 0.0014). Five patients (0.5%) required reoperation for generator erosion (two dual, three single chamber, P = not significant) and a further five for drainage of haematoma or a serous fluid collection (three dual, two single chamber, P = not significant). Complications that did not require reoperation were also' rare. Undersensing occurred in 10 patients (0-90/o). Atrial undersensing (n = 8) was significantly more common than ventricular undersensing (n = 2, P = 0.017). All patients were successfully treated by reprogramming of sensitivity. Superficial wound infection was treated successfully with antibiotics in nine patients (six dual, three single chamber, P = not significant). Three A temporary pacing lead was present at the time of permanent pacemaker implantation in 242 patients (22-9%). Prophylactic antibiotics, used at the discretion of the operating physician, were administered preoperatively in 117 patients (11P0%). Use of antibiotics was significantly more common in patients who had a temporary pacing lead at implant (74 (30 6%) of 242 patients) than in those who did not (43 (5 3%) of 817 patients, P < 0-0001). Only 27 (1.6%) of 1632 pacing leads used were active fixation (screw in) leads.
INTRAOPERATIVE COMPLICATIONS
The most common intraoperative complication was inadvertent arterial puncture which occurred in 27 patients (2-7% of subclavian insertions): no serious sequelae ensued. Pneumothorax required active medical treatment in eight patients (0 8%); five had an intercostal chest drain inserted and three were treated by aspiration. A further 11 patients (1-0%) developed an insignificant pneumothorax (< 10% of pulmonary field in chest x ray film with no symptoms or progression in subsequent chest radiograph). This represents an overall rate of 1-9% of subclavian insertions. There was no significant difference in the pneumothorax rate between 9 (1-6) 6 (1-2) Atrial (n = 10, 1-6% of atrial leads)* Ventricular (n = 5, 0 5% of ventricular leads) *Atrial leads were significantly more likely to displace than ventricular leads (P = 0 047). dual chamber (n = 12, 2 1%) and single chamber (n = 7, 1-4%) devices.
COMPLICATIONS REQUIRING REOPERATION
A total of 35 patients (3-3%) required reoperation within the first two months after implant. Patients with dual chamber systems were no more likely to require reoperation (n = 20, 3-5%) than those with single chamber devices (n = 15, 3 1%), (P = not significant). Reoperation was performed most frequently for electrode displacement (n = 15 patients, 1 4%). There was no significant difference in the incidence of reoperation for electrode displacement in patients with dual compared with single chamber pacemakers (table 2) . However, reoperation was significantly more often required for atrial (n = 10, 1-6% of atrial leads) than ventricular (n = 5, 0-5% of ventricular leads) electrode displacement. Pacemaker pocket infection required generator and electrode removal with simultaneous (or subsequent) implant of a new system on the contralateral side in 10 patients (0 9%). The incidence of infection was not significantly different between those with dual chamber devices (n = 6, 1 0%) and those with single chamber devices (n = 4, 0 8%) (table 2). Pacing system removal for infection was, however, significantly more common in patients who had a temporary pacing lead in situ at the time of permanent pacemaker implantation (seven (2-9%) of 242) than in those who did not (three (0-4%) of 817, P = 0.0014). Antibiotic prophylaxis did not significantly affect the reoperation rate for infection. Three (2-6%) of 117 patients given prophylactic antibiotic treatment developed pacemaker pocket infection compared with seven (0 7%) of 942 patients who received no antibiotics (P = not significant).
Pacemaker generator erosion in the absence of clinical or microbiological evidence of infection led to reoperation in five patients (0 5%). The incidence of generator erosion was not significantly different for dual chamber (n = 2, 0 3%) compared with single chamber (n = 3, 0 6%) systems. Haematoma or serous fluid collection also required operative drainage in five patients (0 5%); the incidence of this complication was also similar for dual (n = 3, 0 5%) and single (n = 2, 0 4%) chamber pacemakers (table 2) .
Inexperienced operators had a non-significantly higher incidence of each of the four complications that led to reoperation (table 3). The overall incidence of reoperation, however, was significantly greater for patients paced by inexperienced operators (20 of 351, 5 7%) compared to those paced by experienced operators (15 of 708, 2d1%, P = 0-0039).
COMPLICATIONS MANAGED WITHOUT REOPERATION
There were also a small number of complications that did not require reoperation. P or R wave undersensing was the most common of these and occurred in 10 patients (0 9%) (table 4). Dual (n = 6, 10%) and single (n = 4, 0 8%) chamber pacemakers were almost equally affected. Atrial undersensing (n = 8), however, was significantly more common than ventricular undersensing (n = 2, P = 0-017) (table 4). All patients were successfully treated by reprogramming of sensitivity. Superficial wound infection was reported in nine patients (0 8%), six with dual chamber and three with single chamber pacemakers (P = not significant) ( Studies comparing the complication rates of dual versus single chamber pacemaker implantation have previously reported either no difference5 or a higher complication rate for dual than single chamber pacing.6 In neither of these series, however, were any single chamber atrial pacemakers implanted and in both < 25% of the implanted units were dual chamber.56
Our study was undertaken to assess the complication rate in a large tertiary referral centre in the United Kingdom where over 600 new pacemaker implants are performed annually, the majority (> 85%) in accordance with national guidelines. Although most procedures are performed by cardiologists in the training grades (registrars and senior registrars), all such operators at our centre would be considered "frequent implanters" according to criteria used by Parsonnet et The subclavian vein approach, using the introducer method, remains the most widely employed route for pacemaker implantation.8 Although Parsonnet et al7 found that this approach contributed significantly to pacemaker implantation complication rates, they were unable to demonstrate a causal relation between complications and the route of access. Although cephalic cut down has been advocated as the route of choice,7 most pacemakers in our series were implanted by the subclavian approach (at the operator's discretion). The cephalic vein route is relatively unfavourable for introducing two leads and cephalic vein dissection significantly prolongs operation time. The rate of serious pneumothorax in our centre is low (< 1 %). Our low overall complication rate, attributable to experienced high volume operators, is unlikely to be further improved by more frequent use of the cephalic approach. REPEAT OPERATION In our series, the most common reason for reoperation within the first two months after implant was electrode displacement. The overall rate of electrode displacement was 1-4% and essentially similar for single and dual chamber pacemakers. Atrial leads, however, were over three times as likely to displace as ventricular leads. (1 -6%) of 1004 ventricular leads used in our series were active fixation leads.
Pacemaker pocket infection in our series was uncommon with an incidence of reoperation within 2 months of implant of 0 9%. This is at the lower end of reported rates of 1-7%"; however, our true incidence of infection leading to reoperation may be marginally higher as some patients with pocket infection present late.'2 We did not routinely use prophylactic antibiotics in this series. These were administered at the discretion of the operating cardiologist and were used more than five times as frequently in patients who had a temporary pacing lead in place at the time of permanent pacemaker insertion than in those who did not. There is no clear evidence to support the routine use of prophylactic antibiotics for pacemaker implantation. In a large randomised trial involving 431 patients, Muers et In contrast to the two series reporting a benefit from antibiotic prophylaxis, Bluhm et al '5 reported no benefit in a small randomised series of 106 patients undergoing pacemaker implantation. In addition, a large (500 patients) prospective randomised study performed at our own institution showed that, with meticulous preoperative skin preparation, use of a topical antibiotic spray into the pacemaker pocket, and close postoperative follow up, patients gained no advantage from routine prescription of prophylactic antibiotics. '6 Irrespective of the use of antibiotics, patients in our series who had a temporary pacing lead in place at the time of permanent pacemaker implantation were more than seven times as likely to require generator and electrode explant for infection than patients who were not temporarily paced before permanent pacemaker insertion. There seemed to be no obvious relation with duration of temporary pacing, though the absolute number of infected generators was too small to draw a valid conclusion in this regard.
Other problems requiring reoperation were rare and again there was no difference between dual and single chamber pacemakers. Haematoma or serous fluid collection occurred in less than 0 5% of patients. Generator erosion without infection had a similar incidence within two months of implant. Erosion rates may be marginally higher at prolonged follow up, although this has not been our experience previously in patients followed for up to 1 year. '6 In conclusion, permanent pacing in a large tertiary referral cardiac centre with operators experienced in single and dual chamber pacemaker implantation carries a low intraoperative and early postoperative risk. Infection rates are less than 1 % overall and there are no differences between dual and single chamber devices. Pacemaker pocket infection, however, is significantly more likely to occur in patients who have a temporary pacing lead in place at the time of permanent pacemaker implantation. Thus, temporary pacing before implantation should be avoided whenever possible. In addition, patients with temporary pacing leads and unequivocal indication for permanent pacing should undergo permanent implantation at the earliest available opportunity. Although electrode displacement and undersensing occur more frequently with atrial than ventricular leads, dual chamber systems confer no higher risk of these events than do single chamber systems. Indeed, the overall complication rate for dual chamber pacing is no higher than for single chamber pacing.
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